Research and Development

Healthcare events firm Universal WorldEvents has appointed Denise Abbott and Nicola Burns to its Board. Abbott (pictured) joined Universal WorldEvents …

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …

A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …

Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …